182 related articles for article (PubMed ID: 30739164)
21. Dedifferentiated Endometrial Carcinoma: A Rare Aggressive Neoplasm-Clinical, Morphological and Immunohistochemical Features.
Giordano G; Ferioli E; Guareschi D; Tafuni A
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958329
[TBL] [Abstract][Full Text] [Related]
22. Rectal Carcinoma With a Sarcomatoid Component: A Case Report With Detailed Immunohistochemistry, Molecular Analysis, and Literature Review.
Todori M; Yanagawa N; Ito K; Ito Y; Suzuki M; Sugimoto R; Osakabe M; Uesugi N; Sugai T
Int J Surg Pathol; 2023 Dec; 31(8):1548-1552. PubMed ID: 36890707
[No Abstract] [Full Text] [Related]
23. Proteogenomic Characterization of Endometrial Carcinoma.
Dou Y; Kawaler EA; Cui Zhou D; Gritsenko MA; Huang C; Blumenberg L; Karpova A; Petyuk VA; Savage SR; Satpathy S; Liu W; Wu Y; Tsai CF; Wen B; Li Z; Cao S; Moon J; Shi Z; Cornwell M; Wyczalkowski MA; Chu RK; Vasaikar S; Zhou H; Gao Q; Moore RJ; Li K; Sethuraman S; Monroe ME; Zhao R; Heiman D; Krug K; Clauser K; Kothadia R; Maruvka Y; Pico AR; Oliphant AE; Hoskins EL; Pugh SL; Beecroft SJI; Adams DW; Jarman JC; Kong A; Chang HY; Reva B; Liao Y; Rykunov D; Colaprico A; Chen XS; Czekański A; Jędryka M; Matkowski R; Wiznerowicz M; Hiltke T; Boja E; Kinsinger CR; Mesri M; Robles AI; Rodriguez H; Mutch D; Fuh K; Ellis MJ; DeLair D; Thiagarajan M; Mani DR; Getz G; Noble M; Nesvizhskii AI; Wang P; Anderson ML; Levine DA; Smith RD; Payne SH; Ruggles KV; Rodland KD; Ding L; Zhang B; Liu T; Fenyö D;
Cell; 2020 Feb; 180(4):729-748.e26. PubMed ID: 32059776
[TBL] [Abstract][Full Text] [Related]
24. Epithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico Investigation.
Voutsadakis IA
J Clin Med; 2016 Jan; 5(1):. PubMed ID: 26797644
[TBL] [Abstract][Full Text] [Related]
25. Endometrial carcinoma with diffuse melanocytic differentiation: Clinicopathological and molecular analysis of a case with literature review and focus on differential diagnosis.
Arciuolo D; Travaglino A; Santoro A; Raffone A; Pedone Anchora L; Fanfani F; Inzani F; Zannoni GF
Pathol Res Pract; 2022 Oct; 238():154122. PubMed ID: 36174440
[TBL] [Abstract][Full Text] [Related]
26. Yolk Sac Differentiation in Endometrial Carcinoma: Incidence and Clinicopathologic Features of Somatically Derived Yolk Sac Tumors Versus Carcinomas With Nonspecific Immunoexpression of Yolk Sac Markers.
Mills AM; Jenkins TM; Dibbern ME; Atkins KA; Ring KL
Am J Surg Pathol; 2024 Apr; ():. PubMed ID: 38651612
[TBL] [Abstract][Full Text] [Related]
27. Expression of E-Cadherin and N-Cadherin in the Endocervix as a Predictive Factor in Patients with Endometrial Cancer.
Frąszczak K; Barczyński B; Tylus B; Bednarek W
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542521
[TBL] [Abstract][Full Text] [Related]
28. SOX11 and Epithelial-Mesenchymal Transition in Metastatic Serous Ovarian Cancer.
Psilopatis I; Schaefer JI; Arsenakis D; Bolovis D; Levidou G
Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760985
[TBL] [Abstract][Full Text] [Related]
29. Surface-Enhanced Raman Spectroscopy-Based Detection of EMT-Related Targets in Endometrial Cancer: Potential for Diagnosis and Prognostic Prediction.
Ma Y; Ma R; Zhang Z; Jiang H; Li Y; Jiang S; Li Y
Anal Chem; 2024 May; ():. PubMed ID: 38780221
[TBL] [Abstract][Full Text] [Related]
30. EMT-Inducing Transcription Factors, Drivers of Melanoma Phenotype Switching, and Resistance to Treatment.
Tang Y; Durand S; Dalle S; Caramel J
Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32759677
[TBL] [Abstract][Full Text] [Related]
31. Clinical Stratification of High-Grade Ovarian Serous Carcinoma Using a Panel of Six Biomarkers.
Kamble SC; Sen A; Dhake RD; Joshi AN; Midha D; Bapat SA
J Clin Med; 2019 Mar; 8(3):. PubMed ID: 30857227
[TBL] [Abstract][Full Text] [Related]
32. Endometrial Cancer in a Family With RAD51D Gene Mutation.
Gilmore B; Logan L; McKinnon W; Everett E; Bryant BH
Int J Gynecol Pathol; 2024 Mar; ():. PubMed ID: 38661557
[TBL] [Abstract][Full Text] [Related]
33. Identification of Metabolomic Biomarkers for Endometrial Cancer and Its Recurrence after Surgery in Postmenopausal Women.
Audet-Delage Y; Villeneuve L; Grégoire J; Plante M; Guillemette C
Front Endocrinol (Lausanne); 2018; 9():87. PubMed ID: 29593653
[TBL] [Abstract][Full Text] [Related]
34. Correction: Cells expressing PAX8 are the main source of homeostatic regeneration of adult mouse endometrial epithelium and give rise to serous endometrial carcinoma.
Fu DJ; De Micheli AJ; Harlan BA; Bidarimath M; Ellenson LH; Cosgrove BD; Flesken-Nikitin A; Nikitin AY
Dis Model Mech; 2023 Oct; 16(10):. PubMed ID: 37870490
[No Abstract] [Full Text] [Related]
35. TWIST1 expression and clinical significance in type I endometrial cancer and premalignant lesions: A retrospective clinical study.
Shen J; Chen Q; Li N; Bai X; Wang F; Li B
Medicine (Baltimore); 2020 Nov; 99(48):e23397. PubMed ID: 33235117
[TBL] [Abstract][Full Text] [Related]
36. SMARCA4-deficient Uterine Sarcoma and Undifferentiated Endometrial Carcinoma Are Distinct Clinicopathologic Entities.
Kolin DL; Quick CM; Dong F; Fletcher CDM; Stewart CJR; Soma A; Hornick JL; Nucci MR; Howitt BE
Am J Surg Pathol; 2020 Feb; 44(2):263-270. PubMed ID: 31567195
[TBL] [Abstract][Full Text] [Related]
37. The Immunohistochemical Pattern of Epithelial-Mesenchymal Transition Markers In Endometrial Carcinoma.
Rubeša-Mihaljević R; Babarović E; Vrdoljak-Mozetič D; Štemberger-Papić S; Klarić M; Krašević M; Jonjić N
Appl Immunohistochem Mol Morphol; 2020; 28(5):339-346. PubMed ID: 30829665
[TBL] [Abstract][Full Text] [Related]
38. Gemcitabine combination therapies induce apoptosis in uterine carcinosarcoma patient-derived organoids.
Dahl MJ; Lofgren KA; Haugen C; Harmon GE; Hughes SP; Cowden Dahl KD
Front Oncol; 2024; 14():1368592. PubMed ID: 38544842
[TBL] [Abstract][Full Text] [Related]
39. A review of basic to clinical targeted therapy and immunotherapy in uterine serous cancer.
Sun B; Zhao N; Cheng Y; Wang J
Mol Biol Rep; 2023 Aug; 50(8):6901-6912. PubMed ID: 37326746
[TBL] [Abstract][Full Text] [Related]
40. Single-cell RNA-seq reveals the genesis and heterogeneity of tumor microenvironment in pancreatic undifferentiated carcinoma with osteoclast-like giant-cells.
Wang X; Miao J; Wang S; Shen R; Zhang S; Tian Y; Li M; Zhu D; Yao A; Bao W; Zhang Q; Tang X; Wang X; Li J
Mol Cancer; 2022 Jun; 21(1):133. PubMed ID: 35733218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
